Nasdaq · Healthcare

SS Innovations International, Inc. (SSII)

As-reported financials and recent SEC filings for SS Innovations International, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.

Snapshot

Revenue

$42.5M

Net income

$-12.1M

Net margin

-28.5%

Diluted EPS

$-0.06

ROE

-31.7%

P/E (TTM)

—

Market cap

—

Debt / equity

—

Income statement (as reported)

Line	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	$42.5M	$20.6M	$5.9M	$1.4M	—
Gross profit	$19.5M	$8.5M	$725,528	$60,577	—
Operating income	$-8.2M	$-19.0M	$-20.3M	$-3.0M	—
Net income	$-12.1M	$-19.2M	$-20.9M	$-3.2M	$-1.5M
Diluted EPS	$-0.06	$-0.11	$-0.14	$-0.03	$-0.01

Source: company XBRL financial statements on SEC EDGAR.

Recent SEC filings

8-K2026-06-30

8-K2026-06-18

424B52026-06-18

8-K2026-06-15

S-82026-06-08

42026-06-04

42026-06-04

8-K2026-06-04

Largest Healthcare peers

UNH

UNITEDHEALTH GROUP INC

All Healthcare companies →

Go deeper on SSII

Search SS Innovations International, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.

Start free

Or check your whole portfolio free — no account needed.

Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.